Abstract 5045: Pharmacokinetics and pharmacodynamics of MEDI0680, a fully human anti-PD1 monoclonal antibody, in patients with advanced malignancies

MLA

Chelsea Black, et al. “Abstract 5045: Pharmacokinetics and Pharmacodynamics of MEDI0680, a Fully Human Anti-PD1 Monoclonal Antibody, in Patients with Advanced Malignancies.” Cancer Research, vol. 77, July 2017, p. 5045. EBSCOhost, https://doi.org/10.1158/1538-7445.am2017-5045.

APA

Chelsea Black, Joyson Joseph Karakunnel, Bo Zheng, Xizhe Gao, Matthew Joseph Gribbin, Lorin Roskos, Rajesh Narwal, & Xuyang Song. (2017). Abstract 5045: Pharmacokinetics and pharmacodynamics of MEDI0680, a fully human anti-PD1 monoclonal antibody, in patients with advanced malignancies. Cancer Research, 77, 5045. https://doi.org/10.1158/1538-7445.am2017-5045

Chicago

Chelsea Black, Joyson Joseph Karakunnel, Bo Zheng, Xizhe Gao, Matthew Joseph Gribbin, Lorin Roskos, Rajesh Narwal, and Xuyang Song. 2017. “Abstract 5045: Pharmacokinetics and Pharmacodynamics of MEDI0680, a Fully Human Anti-PD1 Monoclonal Antibody, in Patients with Advanced Malignancies.” Cancer Research 77 (July): 5045. doi:10.1158/1538-7445.am2017-5045.